Breaking News: Just after publication of this article, GlaxoSmithKline announced that it had withdrawn from the bidding for Pfizer's consumer healthcare business. For updated coverage, see sidebar.
Pfizer Inc. hopes to divest its consumer healthcare business for as much as $20bn and GlaxoSmithKline PLC has emerged as the likely top bidder; however, previous statements from...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?